Skip to main content
Premium Trial:

Request an Annual Quote

GVK Biosciences Teams with Indiana CTSI on Biomarker Resource

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GVK Biosciences today said that it has partnered with the Indiana Clinical and Translational Sciences Institute to provide researchers across the US with access to GVK's Clinical Biomarker Database.

According to GVK, the Indiana CTSI Bioinformatics Core and the Indiana Institute for Personalized Medicine will work together to manage the process by which researchers can access the new resource. The database, also known as GOBIOM, is a "comprehensive collection" of biomarkers associated with a variety of therapeutic areas reported in global clinical trials, as well as clinical and preclinical studies.

GOBIOM will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.

Hyderabad, India-based GVK noted that the agreement was facilitated by the Indiana Economic Development Corporation during a February economic mission to India.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.